18
Views
10
CrossRef citations to date
0
Altmetric
Original Experimental and Clinical Research

Effect of Moxifloxacin on Bacterial Pathogenicity Factors in Comparison with Amoxicillin, Clarithromycin and Ceftriaxone

Pages 30-37 | Published online: 18 Jul 2013

REFERENCES

  • Dalhoff A, Petersen U, Endermann R. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 1996; 42: 410–425.
  • Blondeau JM. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new “res-piratory quinolones”. J Antimicrob Chemother 1999; 43 (suppl B): 1–11.
  • Jones ME, Staples AM, Critchley I, et al. Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study. Diagn Micr Infec Dis 2000; 37: 203–211.
  • Klugman KP, Capper T. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin. J Antimicrob Chemother 1997; 40: 797–802.
  • Blondeau JM, Felmingham D. In vitro and in vivo activity of moxifloxacin against community respiratory tract pathogens. Clin Drug Invest 1999; 18: 57–78.
  • Wilson R, Kubin R, Ballin I, et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999; 44: 501–513.
  • Burke T, Villanueva C, Mariano H, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clin Ther 1999; 21: 1664–1677.
  • Shibl AM. Effect of antibiotics on adherence of microor-ganisms to epithelial cell surfaces. Rev Infect Dis 1985; 7: 51–65.
  • Braga PC, Sala MT, Dal Sasso M. Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacteri-al virulence factors. Antimicrob Agents Chemother 1999; 43: 1013–1019.
  • Jones GW, Isaacson RE. Proteinaceous bacterial adhesins and their receptors. Crit Rev Microbiol 1983; 10: 229–260.
  • Chopra I, Linton A. The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol 1986; 28: 211–259.
  • Scheld WM, Zak O, Vosbeck K, Sande MA. Bacterial adhesion in the pathogenesis of infective endocarditis: effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rab-bits. J Clin Invest 1981; 68: 1381–1384.
  • Reynolds PE. Inhibitors of bacterial cell wall synthesis. Symp Soc Gen Microbiol 1985; 38: 13–40.
  • Tai PC, Davis BD. The action of antibiotics on the ribosome. Symp Soc Gen Microbiol 1985; 38: 41–68.
  • Atkinson BA, Amaral L. Sublethal concentrations of antibiotics, effects on bacteria and the immune system. Crit Rev Microbiol 1982; 9: 101–138.
  • National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Eleventh Informational Supplement; M 100-S 11. NCCLS 2001, Villanova, PA.
  • Drago L, De Vecchi E, Mombelli B, Nicola L, Valli M, Gismondo MR Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother 2001; 48: 37–45
  • Vrane SJ, Zagar Z, Kurbel S. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated Escherichia coll. J Chemother 1996; 8: 254–260.
  • Lorian V, Ernst J. Effects of antibiotics on bacterial structure and their pathogenicity. Pathol Biol 1987; 35: 1370–1376.
  • Sonstein SA, Burnham JC. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. Diagn Micr Infect Dis 1993; 16: 227–289.
  • Desnottes JF, Diallo N. Effect of sparfloxacin on Staphylococcus aureus adhesiveness and phagocytosis. J Antimicrob Chemother 1994; 34: 737–746.
  • Phillips I, Culebras E, Moreno F, Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987; 20: 632–638.
  • Piddock LJ, Walters RN, Diver JM. Correlation of quinolone MIC and inhibition of DNA, RNA and protein syn-thesis and induction of the SOS response in Escherichia coll. Antimicrob Agents Chemother 1990; 34: 2331–2336.
  • Guan L, Burnham JC. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity. J Antimicrob Chemother 1992; 29: 529–538.
  • Walters RN, Piddock II, Wise R. The effect of mutations in the SOS response on the kinetics of quinolone killing. J Antimicrob Chemother 1989; 24: 863–873.
  • Tsang KW, Rutman A, Kanthakumar K, et al. The effects of low concentrations of antibiotics on epithelial dam-age caused by non-typable Haemophilus influenzae and bac-terial morphology. J Antimicrob Chemother 1995; 36: 545–549.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.